Literature DB >> 6523308

Antifungal activity of four antifungal drugs in the cutaneous retention time test.

A Polak.   

Abstract

The protective prophylactic activity of tolciclate, bifonazole, oxiconazole and Ro 14-4767/002 which may reflect their presence in the horny layer was examined in guinea pigs. Guinea pigs were topically treated with the drug and infected on the application site with Trichophyton mentagrophytes spores at various time intervals. Tolciclate showed the highest prophylactic activity, followed by oxiconazole, Ro 14-4767/002 and bifonazole.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6523308     DOI: 10.1080/00362178485380781

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


  6 in total

Review 1.  An overview of topical antifungal therapy in dermatomycoses. A North American perspective.

Authors:  A K Gupta; T R Einarson; R C Summerbell; N H Shear
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

2.  Activities of compound G2 isolated from alfalfa roots against dermatophytes.

Authors:  R Evron; I Polacheck; M Guizie; M Levy; U Zehavi
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

Review 3.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 4.  Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.

Authors:  M Haria; H M Bryson
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

5.  Toxicity of intravitreal oxiconazole.

Authors:  J A Schulman; G A Peyman; J Dietlein; R Fiscella
Journal:  Int Ophthalmol       Date:  1989-05       Impact factor: 2.031

6.  Biopharmaceutical Development of a Bifonazole Multiple Emulsion for Enhanced Epidermal Delivery.

Authors:  Joaquim Suñer-Carbó; Ana Calpena-Campmany; Lyda Halbaut-Bellowa; Beatriz Clares-Naveros; María José Rodriguez-Lagunas; Elena Barbolini; Joanna Zamarbide-Losada; Antonio Boix-Montañés
Journal:  Pharmaceutics       Date:  2019-02-02       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.